2016 经皮冠状动脉介入治疗术后运动康复专家共识

2016-07-30 中国医师协会心血管内科医师分会 中国介入心脏病学杂志.2016,24(7):361-369.

中国PCI 术后康复仍处于起步阶段。广大介入医师的关注重点仍是发病急性期的抢救与治疗,对运动康复的理论和实践缺乏了解。PCI 术后的运动康复缺失引起的心血管疾病的复发率风险居高不下、医疗开支加重及致残率增高等都加重了个人、家庭与社会的负担。因此,我国PCI 术后运动康复的开展迫在眉睫、势在必行。

中文标题:

2016 经皮冠状动脉介入治疗术后运动康复专家共识

发布日期:

2016-07-30

简要介绍:

经皮冠状动脉介入治疗( percutaneous coronaryintervention,PCI) 已成为冠心病患者最重要的血运重建手段。

然而,仅通过 PCI 术和药物治疗并不能持续有效改善患者的预后。PCI 术既不能逆转或减缓冠状动脉粥样硬化的生物学进程,也不能消除冠心病危险因素。多数患者存在的术后运动耐量下降及焦虑抑郁等精神问题,不仅严重影响生活质量,也给家庭及国家带来巨大经济负担和劳动力损失。因此,运动康复及二级预防在发达国家蓬勃发展,并成为 PCI 术后治疗的重要辅助手段。

目前,国际运动康复蓬勃发展。美国国家心血管数据库Cath PCI 注册研究资料显示,美国PCI 术后参与运动康复的比例约为 60%。随着医学整体观念对冠心病慢性进展性、多因素相关性的认识逐渐加深,运动康复从以预防急性心肌梗死后长期卧床相关并发症、改善症状及提高功能水平为目的,转变为以减缓/抑制动脉粥样硬化进展、预防冠心病发展、减少心血管事件发生及降低再次发生率和死亡率、延长寿命、提高运动耐量和生活质量为目的。特别是症状限制性心肺运动试验( cardiopulmonary exercise testing,CPET) 对人体整体功能状态客观定量评估的广泛应用,使心血管疾病等慢性病安全有效的个体化运动康复和治疗效果评估得以精准实现。

中国 PCI 术后康复仍处于起步阶段。广大介入医师的关注重点仍是发病急性期的抢救与治疗,对运动康复的理论和实践缺乏了解。PCI 术后的运动康复缺失引起的心血管疾病的复发率风险居高不下、医疗开支加重及致残率增高等都加重了个人、家庭与社会的负担。因此,我国 PCI 术后运动康复的开展迫在眉睫、势在必行。

制定者:
中国医师协会心血管内科医师分会(CCCP,Chinese College of Cardiovascular Physicians)
预防与康复专业委员会

相关资料下载:
[AttachmentFileName(sort=100, fileName=2016 经皮冠状动脉介入治疗术后运动康复专家共识)] GetToolGuiderByIdResponse(projectId=1, id=8b1001c001261a58, title=2016 经皮冠状动脉介入治疗术后运动康复专家共识, enTitle=, guiderFrom=中国介入心脏病学杂志.2016,24(7):361-369., authorId=null, author=, summary=中国PCI 术后康复仍处于起步阶段。广大介入医师的关注重点仍是发病急性期的抢救与治疗,对运动康复的理论和实践缺乏了解。PCI 术后的运动康复缺失引起的心血管疾病的复发率风险居高不下、医疗开支加重及致残率增高等都加重了个人、家庭与社会的负担。因此,我国PCI 术后运动康复的开展迫在眉睫、势在必行。, cover=, journalId=null, articlesId=null, associationId=315, associationName=中国医师协会心血管内科医师分会, associationIntro=null, copyright=0, guiderPublishedTime=Sat Jul 30 00:00:00 CST 2016, originalUrl=, linkOutUrl=, content=<p class="MsoNormal">经皮冠状动脉介入治疗( percutaneous coronaryintervention,PCI) 已成为冠心病患者最重要的血运重建手段。</p><p class="MsoNormal">然而,仅通过 PCI 术和药物治疗并不能持续有效改善患者的预后。PCI 术既不能逆转或减缓冠状动脉粥样硬化的生物学进程,也不能消除冠心病危险因素。多数患者存在的术后运动耐量下降及焦虑抑郁等精神问题,不仅严重影响生活质量,也给家庭及国家带来巨大经济负担和劳动力损失。因此,运动康复及二级预防在发达国家蓬勃发展,并成为 PCI 术后治疗的重要辅助手段。</p><p class="MsoNormal">目前,国际运动康复蓬勃发展。美国国家心血管数据库Cath PCI 注册研究资料显示,美国PCI 术后参与运动康复的比例约为 60%。随着医学整体观念对冠心病慢性进展性、多因素相关性的认识逐渐加深,运动康复从以预防急性心肌梗死后长期卧床相关并发症、改善症状及提高功能水平为目的,转变为以减缓/抑制动脉粥样硬化进展、预防冠心病发展、减少心血管事件发生及降低再次发生率和死亡率、延长寿命、提高运动耐量和生活质量为目的。特别是症状限制性心肺运动试验( cardiopulmonary exercise testing,CPET) 对人体整体功能状态客观定量评估的广泛应用,使心血管疾病等慢性病安全有效的个体化运动康复和治疗效果评估得以精准实现。</p><p class="MsoNormal">中国 PCI 术后康复仍处于起步阶段。广大介入医师的关注重点仍是发病急性期的抢救与治疗,对运动康复的理论和实践缺乏了解。PCI 术后的运动康复缺失引起的心血管疾病的复发率风险居高不下、医疗开支加重及致残率增高等都加重了个人、家庭与社会的负担。因此,我国 PCI 术后运动康复的开展迫在眉睫、势在必行。</p><p class="MsoNormal"><o:p></o:p></p> <span style="font-weight: bold;">制定者:</span> <div>中国医师协会心血管内科医师分会(CCCP,Chinese College of Cardiovascular Physicians)</div> <div>预防与康复专业委员会</div> <div><br> 拓展指南:<strong>与<font color="red">经皮冠状动脉介入治疗</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=8b1001c001261a58" title="2016 经皮冠状动脉介入治疗术后运动康复专家共识" target="_blank">2016 经皮冠状动脉介入治疗术后运动康复专家共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=f5a011c001193a6d" title="2015 ACC/AHA/SCAI指南:直接经皮冠状动脉介入治疗ST段抬高型心肌梗死" target="_blank">2015 ACC/AHA/SCAI指南:直接经皮冠状动脉介入治疗ST段抬高型心肌梗死</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=898941c001119331" title="2014 经皮冠状动脉介入治疗(PCI)手术前后抑郁和(或)焦虑中医诊疗专家共识" target="_blank">2014 经皮冠状动脉介入治疗(PCI)手术前后抑郁和(或)焦虑中医诊疗专家共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=5ff741c001086806" title="2014 经皮冠状动脉介入治疗(PCI)术后胸痛中医诊疗专家共识" target="_blank">2014 经皮冠状动脉介入治疗(PCI)术后胸痛中医诊疗专家共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=ed2031c0009595fe" title="2013 EAPCI/ESC 经皮冠状动脉介入治疗桡动脉入路专家共识" target="_blank">2013 EAPCI/ESC 经皮冠状动脉介入治疗桡动脉入路专家共识</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E7%BB%8F%E7%9A%AE%E5%86%A0%E7%8A%B6%E5%8A%A8%E8%84%89%E4%BB%8B%E5%85%A5%E6%B2%BB%E7%96%97" target="_blank">有关经皮冠状动脉介入治疗更多指南</a></ul></div>, tagList=[TagDto(tagId=7363, tagName=经皮冠状动脉介入治疗)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7257, appHits=171, showAppHits=0, pcHits=5833, showPcHits=1964, likes=143, shares=16, comments=7, approvalStatus=1, publishedTime=Fri Aug 26 12:20:04 CST 2016, publishedTimeString=2016-07-30, pcVisible=1, appVisible=1, editorId=5295957, editor=lili, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=lili, createdTime=Fri Aug 26 12:20:04 CST 2016, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 21:19:13 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2016 经皮冠状动脉介入治疗术后运动康复专家共识)])
2016 经皮冠状动脉介入治疗术后运动康复专家共识
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=106078, encodeId=64921060e833, content=好指南,谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Sun Aug 28 06:00:00 CST 2016, time=2016-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=104733, encodeId=ec02104e33e9, content=学习了啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e291719269, createdName=大旺旺, createdTime=Fri Aug 26 14:06:00 CST 2016, time=2016-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=104645, encodeId=bcfe1046456a, content=继续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Fri Aug 26 12:33:00 CST 2016, time=2016-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=104646, encodeId=2dba10464644, content=继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Fri Aug 26 12:33:00 CST 2016, time=2016-08-26, status=1, ipAttribution=)]
    2016-08-28 flysky120

    好指南,谢谢

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=106078, encodeId=64921060e833, content=好指南,谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Sun Aug 28 06:00:00 CST 2016, time=2016-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=104733, encodeId=ec02104e33e9, content=学习了啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e291719269, createdName=大旺旺, createdTime=Fri Aug 26 14:06:00 CST 2016, time=2016-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=104645, encodeId=bcfe1046456a, content=继续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Fri Aug 26 12:33:00 CST 2016, time=2016-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=104646, encodeId=2dba10464644, content=继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Fri Aug 26 12:33:00 CST 2016, time=2016-08-26, status=1, ipAttribution=)]
    2016-08-26 大旺旺

    学习了啊

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=106078, encodeId=64921060e833, content=好指南,谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Sun Aug 28 06:00:00 CST 2016, time=2016-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=104733, encodeId=ec02104e33e9, content=学习了啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e291719269, createdName=大旺旺, createdTime=Fri Aug 26 14:06:00 CST 2016, time=2016-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=104645, encodeId=bcfe1046456a, content=继续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Fri Aug 26 12:33:00 CST 2016, time=2016-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=104646, encodeId=2dba10464644, content=继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Fri Aug 26 12:33:00 CST 2016, time=2016-08-26, status=1, ipAttribution=)]
    2016-08-26 doctorJiangchao

    继续学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=106078, encodeId=64921060e833, content=好指南,谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Sun Aug 28 06:00:00 CST 2016, time=2016-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=104733, encodeId=ec02104e33e9, content=学习了啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e291719269, createdName=大旺旺, createdTime=Fri Aug 26 14:06:00 CST 2016, time=2016-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=104645, encodeId=bcfe1046456a, content=继续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Fri Aug 26 12:33:00 CST 2016, time=2016-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=104646, encodeId=2dba10464644, content=继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Fri Aug 26 12:33:00 CST 2016, time=2016-08-26, status=1, ipAttribution=)]
    2016-08-26 doctorJiangchao

    继续关注

    0